Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.

@article{Chatelain1998AntihypertensiveAN,
  title={Antihypertensive and natriuretic effects of CGS 30440, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase 24.11.},
  author={R. Chatelain and R. Ghai and A. Trapani and L. Odorico and B. Dardik and S. De Lombaert and R. Lappe and C. Fink},
  journal={The Journal of pharmacology and experimental therapeutics},
  year={1998},
  volume={284 3},
  pages={
          974-82
        }
}
  • R. Chatelain, R. Ghai, +5 authors C. Fink
  • Published 1998
  • Chemistry, Medicine
  • The Journal of pharmacology and experimental therapeutics
Dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitors, by decreasing angiotensin-II production and by preventing the degradation of atrial natriuretic peptide (ANP), may be useful for the treatment of hypertension and congestive heart failure. The thiol dipeptide CGS 30440 (prodrug of CGS 30008, IC50: ACE/NEP = 19/2 nM) administered to rats (10 mg/kg p.o.) inhibited lung tissue ACE activity by 98% and 61% at 1 and 24 hr (P < .001) and inhibited the angiotensin-I… Expand
Atrial natriuretic peptide mimetics and vasopeptidase inhibitors.
  • G. Sagnella
  • Chemistry, Medicine
  • Cardiovascular research
  • 2001
...
1
2
3
...

References

SHOWING 1-10 OF 118 REFERENCES
Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension.
Cardiovascular effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme BMS-182657 in experimental hypertension and heart failure.
Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
...
1
2
3
4
5
...